NCT02181426View on ClinicalTrials.gov

Dose Response of Ketorolac in Knee Arthroscopy

NACompletedINTERVENTIONAL

Enrollment

112

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

December 15, 2016

Study Completion Date

December 15, 2016

Conditions

Meniscectomy

Interventions

DRUG

Ketorolac Dose

Subjects will be assigned an enrollment number. Enrollment numbers will be assigned consecutively in the order of study enrollment. Based on the enrollment number, subjects will be randomized by a pre-determined computer randomization list created by a statistician to receive a ketorolac dose (0, 7.5, 15, 30 mg).

Trial Locations (1)

29461

Medical University of South Carolina, Charleston

All Listed Sponsors

lead

Medical University of South Carolina

OTHER

NCT02181426 - Dose Response of Ketorolac in Knee Arthroscopy | Biotech Hunter | Biotech Hunter